Developing therapeutics for autism

Developing therapeutics for autism

At Autica Bio, we use a novel, scalable, brain organoid model to study genotype, phenotype, and epigenetic variations underlying autism.

Science for Good

Using stem cells from real patients with autism, we’ve identified promising therapeutic targets that we’re continuing to research, paving the way for future drug development and improved treatment options.

Science for Good

Using stem cells from real patients with autism, we’ve identified promising therapeutic targets that we’re continuing to research, paving the way for future drug development and improved treatment options.

Serum-Free Embryoid Bodies

We apply brain organoid technology to understand complex interactions between genes and cells in autism models.

Genetics

We’re analyzing genetic and epigenetic data from real patients to identify promising therapeutic targets.

Drug Discovery

We multiplex genetics and neurobiology to research potential targets that regulate signaling and help manage autism symptoms.

Our Story

Autica Bio is an early-stage drug discovery company dedicated to rigorous science that will drive new therapeutic options. Our work is driven by a highly experienced scientific advisory board. With a focus on hope through science, we are dedicated to advancing knowledge that can improve outcomes for individuals with autism and their families.

Support Our Research

Autica Bio is an early-stage drug discovery company dedicated to rigorous science that will drive new therapeutic options. Join us in supporting Autica Bio’s promising research to bring hope to patients and their families.

Support Our Research

Autica Bio is an early-stage drug discovery company dedicated to rigorous science that will drive new therapeutic options. Join us in supporting Autica Bio’s promising research to bring hope to patients and their families.